These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8855965)

  • 1. Expression of the extracellular matrix protein tenascin in malignant and benign ovarian tumours.
    Wilson KE; Langdon SP; Lessells AM; Miller WR
    Br J Cancer; 1996 Oct; 74(7):999-1004. PubMed ID: 8855965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of tenascin-C splicing domains in urothelial carcinomas of the urinary bladder.
    Berndt A; Anger K; Richter P; Borsi L; Brack S; Silacci M; Franz M; Wunderlich H; Gajda M; Zardi L; Neri D; Kosmehl H
    J Cancer Res Clin Oncol; 2006 Aug; 132(8):537-46. PubMed ID: 16788848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA expression and protein distribution of the unspliced tenascin-C isoform in prostatic adenocarcinoma.
    Katenkamp K; Berndt A; Hindermann W; Wunderlich H; Haas KM; Borsi L; Zardi L; Kosmehl H
    J Pathol; 2004 Jul; 203(3):771-9. PubMed ID: 15221936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tenascin-C patterns and splice variants in actinic keratosis and cutaneous squamous cell carcinoma.
    Dang C; Gottschling M; Roewert J; Forschner T; Stockfleth E; Nindl I
    Br J Dermatol; 2006 Oct; 155(4):763-70. PubMed ID: 16965426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of the cdx2 gene in benign intestinal-type mucinous ovarian tumors].
    Gaggero G; Sola S; Mora M; Fulcheri E
    Pathologica; 2003 Aug; 95(4):185-91. PubMed ID: 14577202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunohistochemical perspective of PPAR beta and one of its putative targets PDK1 in normal ovaries, benign and malignant ovarian tumours.
    Ahmed N; Riley C; Quinn MA
    Br J Cancer; 2008 Apr; 98(8):1415-24. PubMed ID: 18349831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in tenascin-C isoform expression in invasive and preinvasive breast disease.
    Adams M; Jones JL; Walker RA; Pringle JH; Bell SC
    Cancer Res; 2002 Jun; 62(11):3289-97. PubMed ID: 12036947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines.
    Wilson KE; Bartlett JM; Miller EP; Smyth JF; Mullen P; Miller WR; Langdon SP
    Br J Cancer; 1999 May; 80(5-6):685-92. PubMed ID: 10360644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic analysis of TGF-beta1 in ovarian neoplasia.
    Cardillo MR; Yap E; Castagna G
    J Exp Clin Cancer Res; 1997 Mar; 16(1):49-56. PubMed ID: 9148861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tenascin-C in primary Merkel cell carcinoma.
    Koljonen V; Jahkola T; Tukiainen E; Granroth G; Haglund C; Böhling T
    J Clin Pathol; 2005 Mar; 58(3):297-300. PubMed ID: 15735164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta regulates expression of tenascin alternative-splicing isoforms in fetal rat lung.
    Zhao Y; Young SL
    Am J Physiol; 1995 Feb; 268(2 Pt 1):L173-80. PubMed ID: 7532367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel splice variants of human tenascin-C mRNA identified in normal and bullous keratopathy corneas.
    Saghizadeh M; Khin HL; Bourdon MA; Kenney MC; Ljubimov AV
    Cornea; 1998 May; 17(3):326-32. PubMed ID: 9603390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opposite regulation of tenascin-C and tenascin-X in MeLiM swine heritable cutaneous malignant melanoma.
    Geffrotin C; Horak V; Créchet F; Tricaud Y; Lethias C; Vincent-Naulleau S; Vielh P
    Biochim Biophys Acta; 2000 Dec; 1524(2-3):196-202. PubMed ID: 11113568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metallothionein expression and nuclear size in benign, borderline, and malignant serous ovarian tumours.
    Tan Y; Sinniah R; Bay BH; Singh G
    J Pathol; 1999 Sep; 189(1):60-5. PubMed ID: 10451489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenascin-C expression and distribution in cultured human chondrocytes and chondrosarcoma cells.
    Ghert MA; Qi WN; Erickson HP; Block JA; Scully SP
    J Orthop Res; 2002 Jul; 20(4):834-41. PubMed ID: 12168675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Switch to an invasive growth phase in melanoma is associated with tenascin-C, fibronectin, and procollagen-I forming specific channel structures for invasion.
    Kääriäinen E; Nummela P; Soikkeli J; Yin M; Lukk M; Jahkola T; Virolainen S; Ora A; Ukkonen E; Saksela O; Hölttä E
    J Pathol; 2006 Oct; 210(2):181-91. PubMed ID: 16924594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma.
    Hindermann W; Berndt A; Borsi L; Luo X; Hyckel P; Katenkamp D; Kosmehl H
    J Pathol; 1999 Dec; 189(4):475-80. PubMed ID: 10629546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin-C protein expression and mRNA splice variants in thyroid carcinoma.
    Tseleni-Balafouta S; Gakiopoulou H; Fanourakis G; Voutsinas G; Balafoutas D; Patsouris E
    Exp Mol Pathol; 2006 Apr; 80(2):177-82. PubMed ID: 16259977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the extracellular matrix protein tenascin in laryngeal epithelial lesions: correlation with fibronectin, CD44, cathepsin D and proliferation indices.
    Goussia AC; Ioachim EE; Peschos D; Assimakopoulos DA; Skevas A; Agnantis NJ
    Virchows Arch; 2000 Jun; 436(6):579-84. PubMed ID: 10917172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MUC1 splice variants in benign and malignant ovarian tumours.
    Obermair A; Schmid BC; Packer LM; Leodolter S; Birner P; Ward BG; Crandon AJ; McGuckin MA; Zeillinger R
    Int J Cancer; 2002 Jul; 100(2):166-71. PubMed ID: 12115565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.